Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways

Molecular Cancer Therapeutics

Volumn 3, Issue 2, 2004, Pages 187-197

  Zhang, Xu Dong ^a   Gillespie, Susan K ^a   Hersey, Peter ^a  

^a NEWCASTLE MATER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE INHIBITOR; CYTOCHROME C; DEOXYRIBONUCLEASE; MITOCHONDRIAL ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; STAUROSPORINE; STAUROSPORINE DERIVATIVE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; GENE ACTIVATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; CARRIER PROTEINS; CASPASES; CELL LINE, TUMOR; CYTOCHROMES C; CYTOSOL; ENZYME ACTIVATION; FLAVOPROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANOMA; MEMBRANE POTENTIALS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PROTEIN CONFORMATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STAUROSPORINE; TIME FACTORS;

EID: 4444372444     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Debatin KM, Poncet D, Kroemer G. Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene, 2002;21:8786-803.
2. Lewanski CR, Gullick WJ. Radiotherapy and cellular signaling. Lancet Oncol, 2001;2:366-70.
3. Wesselborg S, Engels IH, Rossmann E, Los M, Schulze-Osthoff K. Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD965 receptor/ligand interaction. Blood, 1999;93:3053-63.
4. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science, 1998;281:1305-8.
5. Green DR, Reed JC. Mitochondria and apoptosis. Science, 1998;281: 1309-12.
6. 2+: a control point for apoptosis. Science, 2003; 300:135-9.
7. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science, 1998; 281:1312-6.
8. Cryns V, Yuan J. Proteases to die for. Genes Dev, 1998;12:1551-70.
9. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell, 1996;86:145-57.
10. Susin SA, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med, 1999;189:381-93.
11. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 2000;102:33-42.
12. Verhagen AM, Ekert PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell, 2000;102:43-53.
13. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature, 2001;412:95-9.
14. Hegde R, Srinivasula SM, Zhang Z, et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem, 2002; 277:432-8.
15. Verhagen AM, Silke J, Ekert PG, et al. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J Biol Chem, 2002;277:445-54.
16. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 1997;91:479-89.
17. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science, 1998;281:1322-6.
18. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature, 1999;399:483-7.
19. Chang EH, Wei MC, Weiler S, et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell, 2001;8:705-11.
20. Bouillet P, Strasser A. BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci, 2002;115:1567-74.
21. Tafani M, Minchenko DA, Serroni A, Farber JL. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine. Cancer Res, 2001;61:2459-66.
22. Tafani M, Cohn JA, Karpinich NO, et al. Regulation of intracellular pH mediates Bax activation in HeLa cells treated with staurosporine or tumor necrosis factor-α. J Biol Chem, 2002;277:49569-76.
23. Yuste VJ, Sanchez-Lopez I, Sole C, et al. The prevention of the staurosporine-induced apoptosis by Bcl-X(L), but not by Bcl-2 or caspase inhibitors, allows the extensive differentiation of human neuroblastoma cells. J Neurochem, 2002;80:126-39.
24. Xue LY, Chiu SM, Oleinick NL. Staurosporine-induced death of MCF-7 human breast cancer cells: distinction between caspase-3-dependent steps of apoptosis and the critical lethal lesions. Exp Cell Res, 2003; 283:135-45.
25. Belmokhtar CA, Hillion J, Segal-Bendirdjian E. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms. Oncogene, 2001;20:3354-62.
26. Hersey P. Advances in the non-surgical treatment of melanoma. Exp Opin Investig Drugs, 2002;11:75-85.
27. Hersey P, Zhang XD. Overcoming resistance of cancer cells to apoptosis. J Cell Physiol, 2003;196:9-18.
28. Zhang XD, Franco A, Myers K, Gray C, Nguyen T, Hersey P. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res, 1999;59:2747-53.
29. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by Smac/DIABLO release from mitochondria. Cancer Res, 2001;61:7339-48.
30. Johnson DE, Gastman BR, Wieckowski E, et al. Inhibitor of apoptosis protein hILP undergoes caspase-mediated cleavage during T lymphocyte apoptosis. Cancer Res, 2000;60:1818-23.
31. Desagher S, Osen-Sand A, Nichols A, et al. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol, 1999;144:891-901.
32. Bellosillo B, Villamor N, Lopez-Guillermo A, et al. Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. Blood, 2002;100: 1810-6.
33. Chinopoulos C, Starkov A, Fiskum G. Cyyclosporin A-insensitive permeability transition in brain mitochondria: inhibition by 2-aminoethoxydiphenyl borate. J Biol Chem, 2003;278:273-89.
34. Poot M, Hosier S, Swisshelm K. Distinct patterns of mitochondrial changes precede induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxypheny) retinamide in MCF-7 breast cancer cells. Exp Cell Res, 2002;279:128-40.
35. Stepczynska A, Lauber K, Engels IH, et al. Staurosporine and conventional anticancer drugs induce overlapping, yet distinct pathways of apoptosis and caspase activation. Oncogene, 2001;20: 1193-202.
36. Daugas E, Susin SA, Zamzami N, et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J, 2000;14: 729-39.
37. Ruefli AA, Ausserlechner MJ, Bernhard D, et al. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc Natl Acad Sci, 2001;98:10833-8.
38. Rosato FIR, Almenara JA, Grant S. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Cancer Res, 2003;63: 3637-45.
39. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not Bcl-X. Cell, 1996;87:619-28.
40. Franke TF, Cangley LC. Apoptosis. A bad kinase makes good. Nature, 1997;390:116-7.
41. Songyang Z, Baltimore D, Cantley LC, Kaplan DR, Franke TF. Interleukin 3-dependent survival by the Akt protein kinase. Proc Natl Acad Sci USA, 1997;94:11345-50,
42. Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell, 1995;80:285-91.
43. Yamaki K, Hong J, Hiraizumi K, Ahn JW, Zee O, Ohuchi K. Participation of various kinases in staurosporine induced apoptosis RAW 264.7 cells. J Pharm Pharmacol, 2002;54:1535-44.
44. Zhang XD, Borrow JM, Zhang XY, Nguyen T, Hersey P. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria. Oncogene, 2003;22: 2869-81.